title: Lapatinib in early breast cancer--questions to be resolved.
authors.affiliation: Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway. per.lonning@helse-bergen.no
authors.forename: Per Eystein
authors.initials: PE
authors.lastname: Lønning
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D000077341:Lapatinib; D011799:Quinazolines / Q000008:administration & dosage*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D000077341:Lapatinib; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human